2.43
price down icon3.57%   -0.09
after-market After Hours: 2.40 -0.03 -1.23%
loading
Inmed Pharmaceuticals Inc stock is traded at $2.43, with a volume of 82,660. It is down -3.57% in the last 24 hours and down -25.23% over the past month. InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The company is engaged in the research and development of novel, cannabinoid-based, and manufacturing of Pharmaceutical grade cannabinoids. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease, INM-089's pharmacological and IntegraSyn which is a manufacturing system for Pharmaceutical-Grade Cannabinoids.
See More
Previous Close:
$2.52
Open:
$2.56
24h Volume:
82,660
Relative Volume:
0.03
Market Cap:
$4.87M
Revenue:
$4.96M
Net Income/Loss:
$-6.82M
P/E Ratio:
-0.0372
EPS:
-65.4
Net Cash Flow:
$-6.64M
1W Performance:
-9.33%
1M Performance:
-25.23%
6M Performance:
-21.10%
1Y Performance:
-30.89%
1-Day Range:
Value
$2.39
$2.56
1-Week Range:
Value
$2.39
$2.71
52-Week Range:
Value
$1.72
$15.70

Inmed Pharmaceuticals Inc Stock (INM) Company Profile

Name
Name
Inmed Pharmaceuticals Inc
Name
Phone
(604) 669-7207
Name
Address
1445-885 WEST GEORGIA ST., VANCOUVER
Name
Employee
13
Name
Twitter
Name
Next Earnings Date
2024-11-12
Name
Latest SEC Filings
Name
INM's Discussions on Twitter

Compare INM with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Drug Manufacturers - Specialty & Generic icon
INM
Inmed Pharmaceuticals Inc
2.43 5.05M 4.96M -6.82M -6.64M -65.40
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
145.79 66.25B 9.29B 2.52B 2.28B 5.57
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
13.72 42.95B 30.08B 710.16M 4.45B 0.2182
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
9.43 43.30B 14.35B 1.85B 0 0.4023
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
15.45 19.30B 16.54B -1.64B 749.00M -1.45
Drug Manufacturers - Specialty & Generic icon
NBIX
Neurocrine Biosciences Inc
128.23 13.53B 2.41B 305.80M 492.20M 2.95

Inmed Pharmaceuticals Inc Stock (INM) Latest News

pulisher
Jul 31, 2025

What makes InMed Pharmaceuticals Inc. stock price move sharplyAdvanced Screener Entry Points For Consistent Profits - jammulinksnews.com

Jul 31, 2025
pulisher
Jul 31, 2025

What institutional investors are buying InMed Pharmaceuticals Inc. stockChart Pattern Updates For Fast Growth - jammulinksnews.com

Jul 31, 2025
pulisher
Jul 31, 2025

News impact scoring models applied to InMed Pharmaceuticals IncShort Term Gain Strategy with AI Logic - Newser

Jul 31, 2025
pulisher
Jul 31, 2025

What moving averages say about InMed Pharmaceuticals Inc.Free Early Entry Tips With Low Risk Zone - Newser

Jul 31, 2025
pulisher
Jul 31, 2025

What is the risk reward ratio of investing in InMed Pharmaceuticals Inc. stockPost Market Alerts For Every Investor - jammulinksnews.com

Jul 31, 2025
pulisher
Jul 31, 2025

News impact scoring models applied to InMed Pharmaceuticals Inc.Alpha Stock Picks with Chart Confirmation - Newser

Jul 31, 2025
pulisher
Jul 31, 2025

How InMed Pharmaceuticals Inc. stock performs during market volatilityAI Screener Based Stock Summary Report - Newser

Jul 31, 2025
pulisher
Jul 29, 2025

Why InMed Pharmaceuticals Inc. stock attracts strong analyst attentionFree High Yield Stocks With Buy Confirmation - Newser

Jul 29, 2025
pulisher
Jul 29, 2025

Exit strategy if you’re trapped in InMed Pharmaceuticals Inc.Real-Time Setup Summary with ROI Focus - Newser

Jul 29, 2025
pulisher
Jul 29, 2025

Why InMed Pharmaceuticals Inc. stock is on top investor watchlistsWeekly Entry Signal Based Forecast Tool - Newser

Jul 29, 2025
pulisher
Jul 29, 2025

InMed Pharmaceuticals Announces Closing of $5 Million Registered Direct and Private Placement Offerings Priced At-The-Market Under Nasdaq Rules – IT Business Net - IT Business Net

Jul 29, 2025
pulisher
Jul 28, 2025

INM files 8-K on upcoming INM-901 Alzheimer’s data at AAIC 2025 | INM SEC FilingForm 8-K - Stock Titan

Jul 28, 2025
pulisher
Jul 28, 2025

Published on: 2025-07-28 16:29:31 - beatles.ru

Jul 28, 2025
pulisher
Jul 28, 2025

Price Channel Expanding on InMed Pharmaceuticals Inc.’s ChartSecure Capital Picks With Upside Potential Tracked - metal.it

Jul 28, 2025
pulisher
Jul 28, 2025

What are analysts’ price targets for InMed Pharmaceuticals Inc. in the next 12 monthsInvest confidently with expert support - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

InMed to Present INM-901 Data at Alzheimer's Association International Conference (AAIC) 2025 - TradingView

Jul 28, 2025
pulisher
Jul 28, 2025

Promising Alzheimer's Drug INM-901 Demonstrates Breakthrough Results in Advanced Disease Treatment - Stock Titan

Jul 28, 2025
pulisher
Jul 28, 2025

How volatile is InMed Pharmaceuticals Inc. stock compared to the marketAdvanced Screener Guidance From AI Tools - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

Published on: 2025-07-28 04:56:47 - Newser

Jul 28, 2025
pulisher
Jul 28, 2025

Published on: 2025-07-28 03:47:35 - Newser

Jul 28, 2025
pulisher
Jul 28, 2025

What are InMed Pharmaceuticals Inc. company’s key revenue driversPhenomenal returns - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 27, 2025

What are the technical indicators suggesting about InMed Pharmaceuticals Inc.Superior capital gains - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

How strong is InMed Pharmaceuticals Inc. company’s balance sheetUnlock real-time stock alerts for quick profits - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

Is InMed Pharmaceuticals Inc. stock overvalued or undervaluedAchieve rapid portfolio appreciation today - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

Is it the right time to buy InMed Pharmaceuticals Inc. stockGrow your wealth with proven stock picks - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

What are the latest earnings results for InMed Pharmaceuticals Inc.Discover stocks with superior performance - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

Why is InMed Pharmaceuticals Inc. stock attracting strong analyst attentionSky-high return potential - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 25, 2025

What analysts say about InMed Pharmaceuticals Inc. stockUnprecedented profits - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

Can InMed Pharmaceuticals Inc. stock recover from recent declineSuperior portfolio returns - jammulinksnews.com

Jul 25, 2025

Inmed Pharmaceuticals Inc Stock (INM) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$71.19
price down icon 0.90%
$13.68
price down icon 3.12%
$8.74
price down icon 2.89%
drug_manufacturers_specialty_generic RDY
$14.22
price up icon 0.85%
$274.70
price down icon 2.57%
$128.23
price down icon 6.24%
Cap:     |  Volume (24h):